Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...41424344454647484950...
CompanyDrug NameStatusIndication Group
Teva Pharmaceutical Estredox in Phase IISystemic hormonal preparations
Sepracor ESTORRA , Lunesta Approved in USA, submitted for approval in EUNervous system
ImClone Erbitux in Phase IIAntineoplastic & immunomodulating agents
ImClone Erbitux Approved in USAAntineoplastic & immunomodulating agents
ImClone Erbitux Submitted for approval in JapanAntineoplastic & immunomodulating agents
ImClone Erbitux Approved in Switzerland and USAAntineoplastic & immunomodulating agents
ImClone Erbitux accomplished Phase IIIAntineoplastic & immunomodulating agents
ImClone Erbitux accomplished Phase IIIAntineoplastic & immunomodulating agents
Shire EQUETRO Approved in USANervous system
GlaxoSmithKline Epzicom Approved in USA and EUAnti-infectives for systemic use
Baxter International Epoetin Omega in Phase IIBlood & blood forming organs
Spectrum EOquin in Phase IIIAntineoplastic & immunomodulating agents
Prometheus Laboratories Entocort EC Approved in USAAlimentary tract & metabolism
GlaxoSmithKline Entereg Approved in USA, submitted for approval in EUAlimentary tract & metabolism
GlaxoSmithKline Entereg in Phase IIIAlimentary tract & metabolism
Barr Laboratories Enjuvia Approved in USASystemic hormonal preparations
NeuroSearch Endovion accomplished Phase IAntineoplastic & immunomodulating agents
MediGene AG EndoTAG-1 in Phase IIAntineoplastic & immunomodulating agents
Wyeth Enbrel Psoriasis Approved in USA and EUDermatologicals
Wyeth Enbrel IPF in Phase IIRespiratory system
...41424344454647484950...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.